Request to Join
has invited you to join this group
Dr. Baron received his M.D. from the University of Florida, Gainesville (1986). He completed Internal Medicine and Gastroenterology training at the University of Alabama at Birmingham (UAB) during which time he was inducted into the Alpha Omega Alpha Honor Society. He then completed Gastroenterology fellowship training at UAB followed by pancreaticobiliary endoscopy training at Duke University Medical Center. Dr. Baron was a faculty member at UAB from 1993-1998, where he became Associate Professor of Medicine and Director of Therapeutic Endoscopy. From 1998-2013 he was a consultant at Mayo Clinic, Rochester Minnesota as Professor of Medicine and Director of Pancreaticobiliary Endoscopy, and was awarded the Henry S. Plummer distinguished clinician award. Since 2014 he has been Professor of Medicine and Director of Advanced Therapeutic Endoscopy at The University of North Carolina, Chapel Hill. Dr. Baron is nationally and internationally recognized for his skills in advanced therapeutic endoscopy. He is an active member of the American Society for Gastrointestinal Endoscopy (ASGE), which awarded him Master Endoscopist in 2010. He has published more than 600 articles in numerous peer-reviewed journals including the New England Journal of Medicine. In addition, he is co-editor of the textbooks ERCP and Self- Expandable Stents in the Gastrointestinal Tract.
Mark Pimentel, MD, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles, California. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry at the University of Manitoba, Canada. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center in Winnipeg, Manitoba, Canada, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel has been invited to present his work at meetings, grand rounds, and advisory boards in the United States and Internationally. He is a diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Pimentel is also a member of several medical associations including the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society. A few of Dr. Pimentel’s most significant accomplishments include: 1. The discovery of rifaximin as a treatment for irritable bowel syndrome (IBS). 2. Developed the first blood test for IBS on the basis of IBS being derived from acute gastroenteritis. 3. Described the association between IBS and bacterial overgrowth which forms the basis for microbiome therapies in this condition. 4. Uncovered the methanogen (Methanobrevibacter smithii) as an agent for causing constipation in humans.
Dr. Inadomi received a mechanical engineering degree from the Massachusetts Institute of Technology and a medical degree from the University of California, San Francisco (UCSF) where he also completed his internal medicine residency and gastroenterology fellowship. Dr. Inadomi has been on the faculty at the University of New Mexico, the University of Michigan, UCSF and is currently the Head of the Division of Gastroenterology at the University of Washington. Dr. Inadomi is funded by the NIH to conduct health services and outcomes research to optimize the management of Barrett’s esophagus and develop and test novel interventions to increase screening to reduce mortality from colorectal cancer. He has an H-index of 50 and has published 160 papers in peer- reviewed journals including the New England Journal of Medicine, Annals of Internal Medicine, JAMA, Gastroenterology, Hepatology and Gut. He is currently an associate editor for the AGA journal Gastroenterology and is a term member of the NIH DDK-C study section that reviews career development and training grants. John has served as the Chair of the AGA Clinical Practice and Quality Management Committee, and the Clinical Practice section of the AGA Council. He has directed the AGA Spring Post-Graduate Course and the AGA/AASLD Academic Skills Workshop, and is currently the clinical research councilor for the AGA Governing Board.
Shilpa Grover, M.D., M.P.H. is an Assistant Professor of Medicine at Harvard Medical School, an Associate Physician and Director of the Onco-Gastroenterology Program in the Division of Gastroenterology at Brigham and Women’s Hospital. A graduate of Kasturba Medical College, she completed her internal medicine residency and gastroenterology fellowship at Brigham and Women’s Hospital. She received an M.P.H. from the Harvard School of Public Health. Dr. Grover specializes in gastroenterological care for cancer patients with a history of gastrointestinal disease and those who develop complications during the course of cancer treatment. Her research focuses on gastrointestinal toxicity of cancer immunotherapy and molecular targeted agents.
Dr. Wilcox is Professor of Medicine, Surgery and Pediatrics and is the Director of the Division of Gastroenterology and Hepatology at the University of Alabama at Birmingham (UAB). Dr. Wilcox was born and raised in Chattanooga, TN. He earned his medical degree from the Medical College of Georgia in Augusta, GA. His internship and residency were spent at UAB, where he was also a Chief Medical Resident. His gastroenterology training was at the University of California at San Francisco. Dr. Wilcox then joined the faculty at Emory University in Atlanta, Georgia where he was the Chief of Gastroenterology and Endoscopy at Grady Memorial Hospital. He was there for 5 years until moving to UAB in 1995 as an Associate Professor in the Division of Gastroenterology and Hepatology and the Director of Clinical Research in the Division. Dr. Wilcox is actively involved with clinical research as it relates to disorders of the pancreas and biliary tree. He has received a number of awards for teaching and for clinical excellence. He was previously a member of the ABIM Gastroenterology Subspecialty Board. In addition, Dr. Wilcox is on a number of Editorial Boards and was Editor-in- Chief of Clinical Gastroenterology and Hepatology from July 2007 until July 2012. He is an active reviewer for many gastroenterology and internal medicine journals. Dr. Wilcox has authored more than 400 peer-reviewed publications, book chapters, and miscellaneous articles. His clinical research interests include clinical pancreatic disorders, gastrointestinal complications of AIDS, and therapeutic endoscopy.
Dr Sengupta holds Bachelor of Science degrees in Biology and Management Science from the Massachusetts Institute of Technology. He earned his MD from the University of Florida College of Medicine and completed his internship and residency training in Internal Medicine at the Hospital of the University of Pennsylvania, as well as fellowship training in Gastroenterology and Hepatology at Beth Israel Deaconess Medical Center in Boston. He is currently an Assistant Professor at the University of Chicago Medical Center, where he is the Director of Quality Improvement and a General Gastroenterologist. Dr Sengupta’s primary research interests revolve around the outcomes of patients admitted to the hospital with gastrointestinal bleeding. He has national expertise in the management of gastrointestinal bleeding on antithrombotic agents, and the evaluation and outcomes of patients with lower gastrointestinal bleeding. In addition, he has interests in colon cancer screening, and quality indicators during Colonoscopy.
Dr Patwardhan is an Assistant Professor of Medicine at Harvard Medical School. After graduating from Brown University with a degree in Economics he completed his MD degree at the University of Massachusetts Medical School followed by internship and residency in Internal Medicine at Massachusetts General Hospital. He completed his Gastroenterology and Hepatology, and Transplant Hepatology fellowships at Beth Israel Deaconess Medical Center in Boston, where he currently practices. Dr Patwardhan’s primary research interest centers on autoimmune liver disease and complications of portal hypertension. He leads the BIDMC Program in Autoimmune and Cholestatic Liver Diseases and is also actively involved in medical student and residency education.
Dr. Sunanda V. Kane is a Professor of Medicine at the Mayo Clinic in Rochester Minnesota. Dr. Kane has contributed over 135 papers of original research, 50 reviews, and 25 book chapters to the medical literature. She has co-edited a pocket guide to the management of IBD for practitioners, and written a book for patients on self-management. She is the Past Chair of the National Patient Education Committee for the Crohn’s and Colitis Foundation. She served as the first female Associate Editor for Alimentary Pharmacology and Therapeutics and continues to serve editorial roles for Inflammatory Bowel Disease, Gastroenterology&Hepatology, and the Journal of Crohn’s and Colitis. Dr. Kane is currently the President-Elect of the American College of Gastroenterology and sits on the GI Specialty Council of the American Board of Internal Medicine. Within the Division of Gastroenterology and Hepatology, she is the Chair of Quality, where she is responsible for oversight of all quality improvement projects, measuring quality metrics for the faculty, leading annual credentialing reviews, and is an adjunct faculty member to the Mayo Quality Academy. She continues to have a busy clinical practice seeing patients with inflammatory bowel disease, and conducts research in the areas of new therapies, gender-specific issues, and medication adherence. Dr. Kane also teaches the second year Gastroenterology course in the Mayo Medical School, the Medicine residents on the GI inpatient consult service, and Gastroenterology Fellows in clinic, on hospital service and the endoscopy suite.
Sahil Khanna, MBBS, MS is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. He completed Medical School at the All India Institute of Medical Sciences, New Delhi; residency and fellowship at Mayo Clinic, Rochester, MN before joining the Faculty. His research and clinical interests include Epidemiology, Outcomes and Emerging Therapeutics for Clostridium difficile infection, an arena in which he has had numerous publications and presentations. He is directing the C. difficile Clinic, Fecal Microbiota Transplantation program and C. difficile related Clinical Trials at Mayo Clinic, Rochester, MN.
Ken DeVault, MD is Professor and Chair of the Department of Medicine at Mayo Clinic Florida. He received his undergraduate degree from the University of Tennessee and his medical degree from the Bowman Gray School of Medicine at Wake Forest University. He completed his internship and residency in internal medicine at Vanderbilt University and completed a combined clinical and research fellowship at Jefferson Medical College. He is board certified in Internal Medicine and Gastroenterology. Prior to becoming Chair of Medicine, Dr. DeVault was Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic Florida from 2005-2010. He is a member of the Executive Operating Team of Mayo Clinic in Florida and is the Medical Director for Leadership and Organizational Development. He is a Fellow of and Past-President of The American College of Gastroenterology. He is a member of the American Gastroenterological Association, American Society for Gastrointestinal Endoscopy and a fellow of the American College of Physicians. He is also a member of the Vestry of Christ Episcopal Church, one of the largest Episcopal churches in America. Dr. DeVault conducts research on disorders affecting all aspects of the esophagus and has written over 250 book chapters, abstracts, editorials and original articles on subjects ranging from treatment of GERD, dysphagia, esophagitis, and Barrett’s esophagus to laparoscopic antireflux surgery and managed care issues in the treatment of GERD. He also has interest in gastrointestinal health in the third world, improving professionalism in both trainees and practicing physicians and in the development of a diverse and effective health care work force.
Dr. Saltzman is the Director of Endoscopy at the Brigham and Women’s Hospital and the Director of the Brigham and Women’s Hospital Advanced Endoscopy Fellowship Program in Boston, Massachusetts. He is a Professor of Medicine at Harvard Medical School and is actively involved in patient care, teaching, clinical research, and administration. His areas of expertise include upper gastrointestinal hemorrhage and all areas of endoscopy. He has served as the President of the New England Endoscopy Society and as the Governor for the State of Massachusetts for the American College of Gastroenterology. Dr. Saltzman has authored more than 200 original articles, reviews and chapters. His editorial activities include being an Associate Editor of Gastrointestinal Endoscopy and the Section Editor for Diagnostic and Therapeutic Endoscopy for UpToDate. He is the immediate past Chair of the Educational Affairs Committee for the American College of Gastroenterology and currently serves as a trustee for the American College of Gastroenterology.
Dr Charles Kahi is Professor of Clinical Medicine at Indiana University School of Medicine, and Gastroenterology Section Chief at the affiliated Richard L. Roudebush VA Medical Center in Indianapolis, Indiana, USA. His clinical and research interests are colorectal cancer prevention, colonoscopy quality assessment and improvement, serrated polyps, and screening in geriatric populations. Dr Kahi received his M.D. from the American University of Beirut Medical School in Lebanon in 1996. He subsequently completed a Residency and Chief Residency in Internal Medicine, then a Fellowship in Gastroenterology at the Indiana University Medical Center, USA. During his GI fellowship, he obtained a Master’s degree in Clinical Research from Indiana University. Since 2004, he has been an active member of the IU faculty, and is involved in direct patient care, teaching, research, and administration as leader of the GI group at the IU-VA Hospital. He is a Diplomate of the American Board of Internal Medicine in Internal Medicine and Gastroenterology. He is the recipient of several teaching awards, including the Distinguished Teacher Award and Trustees Teaching Award from Indiana University, and has directed regional and national American College of Gastroenterology Postgraduate GI courses. He has maintained continuous research funding since 2005 from the National Cancer Institute, GI professional societies, and Department of Veterans Affairs including VA Merit Review Grants. He has published multiple peer-reviewed research papers, including in high-impact journals such as Annals of Internal Medicine and Gastroenterology. His work also includes multiple reviews, book chapters, and invited editorials, and clinical practice guidelines. He is a frequently invited speaker in national and international scientific GI meetings. He currently serves as Associate Editor for Clinical Gastroenterology and Hepatology, the clinical practice journal of the American Gastroenterological Association, and NEJM Journal Watch Gastroenterology.